Literature DB >> 27182428

Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure.

Kathryn Fitch1, Pamela M Pelizzari2, Bruce Pyenson3.   

Abstract

BACKGROUND: Although the medical and economic burden of heart failure in the United States is already substantial, it will likely grow as the population ages and life expectancy increases. Not surprisingly, most of the heart failure burden is borne by individuals aged ≥65 years, many of whom are in the Medicare population. The population-based utilization and costs of inpatient care for Medicare beneficiaries with heart failure are not well understood by payers and providers.
OBJECTIVE: To create a real-world view of utilization and costs associated with inpatient admissions, readmissions, and admissions to skilled nursing facilities among Medicare fee-for-service (FFS) beneficiaries with heart failure.
METHODS: The study used the 2011 and 2012 Medicare 5% sample limited data set to perform a retrospective analysis of claims data. The look-back year that was used to identify certain patient characteristics was 2011, and 2012 was the analysis period for the study. Beneficiaries with heart failure were defined as those who had ≥1 acute inpatient, emergency department, nonacute inpatient, or outpatient claims in 2012 containing an International Classification of Diseases, Ninth Revision code for heart failure. To be included in the study, beneficiaries with heart failure had to have eligibility for ≥1 months in 2012 and in all 2011 months, with Part A and Part B eligibility in all the study months, and no enrollment in an HMO (Medicare Advantage plan). Utilization of inpatient admissions, inpatient readmissions, and skilled nursing facility admissions in 2012 were reported for Medicare FFS beneficiaries with heart failure and for all Medicare FFS beneficiaries. The costs for key metrics included all allowed Medicare payments in 2012 US dollars.
RESULTS: The 2012 Medicare FFS population for this study consisted of 1,461,935 patients (1,301,545 without heart failure; 160,390 with heart failure); the heart failure prevalence was 11%. The Medicare-allowed cost per member per month (PMPM) was $3395 for a patient with heart failure, whereas the allowed cost for the total Medicare population was $1045 PMPM. The Medicare-allowed amounts for the population with heart failure accounted for 34% of the total annual Medicare FFS population-allowed amounts. The heart failure population constituted 41.5%, 55.3%, and 49.5% of total Medicare FFS inpatient admissions, readmissions, and admissions to skilled nursing facilities, respectively. The costs of inpatient admissions, readmissions, and admissions to skilled nursing facilities among the heart failure population contributed $182 PMPM (17.5%), $58 PMPM (5.6%), and $46 PMPM (4.4%), respectively, to the total Medicare FFS population-allowed cost of $1045 PMPM.
CONCLUSIONS: Medicare FFS beneficiaries with heart failure have high inpatient admission and readmission rates and generate substantial costs. Because a substantial portion of all inpatient admissions are for Medicare beneficiaries with heart failure, it is reasonable for hospitals in Medicare accountable care organizations to focus on more aggressive post-acute care management, including a focus on reducing readmissions for the population with heart failure. Our study findings highlight areas of high service utilization and cost for Medicare patients with heart failure that can be of value to Medicare, Medicare Advantage plans, and providers.

Entities:  

Keywords:  Medicare fee-for-service population; healthcare costs; healthcare utilization; heart failure; inpatient admissions; inpatient readmissions; skilled nursing facilities

Year:  2016        PMID: 27182428      PMCID: PMC4856234     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  8 in total

1.  Observation care--high-value care or a cost-shifting loophole?

Authors:  Christopher W Baugh; Jeremiah D Schuur
Journal:  N Engl J Med       Date:  2013-07-25       Impact factor: 91.245

2.  Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

3.  Paradigm shifts in heart-failure therapy--a timeline.

Authors:  Chana A Sacks; John A Jarcho; Gregory D Curfman
Journal:  N Engl J Med       Date:  2014-09-03       Impact factor: 91.245

4.  Costs of heart failure-related hospitalizations in patients aged 18 to 64 years.

Authors:  Guijing Wang; Zefeng Zhang; Carma Ayala; Hilary K Wall; Jing Fang
Journal:  Am J Manag Care       Date:  2010-10       Impact factor: 2.229

5.  Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.

Authors:  Kathleen T Unroe; Melissa A Greiner; Adrian F Hernandez; David J Whellan; Padma Kaul; Kevin A Schulman; Eric D Peterson; Lesley H Curtis
Journal:  Arch Intern Med       Date:  2010-10-11

6.  Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.

Authors:  Paul A Heidenreich; Nancy M Albert; Larry A Allen; David A Bluemke; Javed Butler; Gregg C Fonarow; John S Ikonomidis; Olga Khavjou; Marvin A Konstam; Thomas M Maddox; Graham Nichol; Michael Pham; Ileana L Piña; Justin G Trogdon
Journal:  Circ Heart Fail       Date:  2013-04-24       Impact factor: 8.790

7.  Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure.

Authors:  Kathryn Fitch; Pamela M Pelizzari; Bruce Pyenson
Journal:  Am Health Drug Benefits       Date:  2016-04

8.  National patterns of risk-standardized mortality and readmission after hospitalization for acute myocardial infarction, heart failure, and pneumonia: update on publicly reported outcomes measures based on the 2013 release.

Authors:  Lisa G Suter; Shu-Xia Li; Jacqueline N Grady; Zhenqiu Lin; Yongfei Wang; Kanchana R Bhat; Dima Turkmani; Steven B Spivack; Peter K Lindenauer; Angela R Merrill; Elizabeth E Drye; Harlan M Krumholz; Susannah M Bernheim
Journal:  J Gen Intern Med       Date:  2014-05-14       Impact factor: 5.128

  8 in total
  9 in total

1.  30-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries.

Authors:  Rishi K Wadhera; Karen E Joynt Maddox; Yun Wang; Changyu Shen; Robert W Yeh
Journal:  JACC Heart Fail       Date:  2018-04-11       Impact factor: 12.035

2.  Interactive Digital e-Health Game for Heart Failure Self-Management: A Feasibility Study.

Authors:  Kavita Radhakrishnan; Paul Toprac; Matt O'Hair; Randolph Bias; Miyong T Kim; Paul Bradley; Michael Mackert
Journal:  Games Health J       Date:  2016-10-24

3.  Racial Disparities in Health Service Utilization Among Medicare Fee-for-Service Beneficiaries Adjusting for Multiple Chronic Conditions.

Authors:  Krupa Gandhi; Eunjung Lim; James Davis; John J Chen
Journal:  J Aging Health       Date:  2017-06-16

4.  Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure.

Authors:  Kathryn Fitch; Pamela M Pelizzari; Bruce Pyenson
Journal:  Am Health Drug Benefits       Date:  2016-04

5.  Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.

Authors:  Domenic A Sica; Pieter Muntendam; Rene L Myers; Jozine M Ter Maaten; Mark E Sale; Rudolf A de Boer; Bertram Pitt
Journal:  JACC Basic Transl Sci       Date:  2018-02-07

6.  The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings.

Authors:  Kathryn Fitch; Jocelyn Lau; Tyler Engel; Joseph J Medicis; John F Mohr; William S Weintraub
Journal:  Clinicoecon Outcomes Res       Date:  2018-12-14

7.  Identifying patterns of health care utilisation among physical elder abuse victims using Medicare data and legally adjudicated cases: protocol for case-control study using data linkage and machine learning.

Authors:  Tony Rosen; Yuhua Bao; Yiye Zhang; Sunday Clark; Katherine Wen; Alyssa Elman; Philip Jeng; Elizabeth Bloemen; Daniel Lindberg; Richard Krugman; Jacquelyn Campbell; Ronet Bachman; Terry Fulmer; Karl Pillemer; Mark Lachs
Journal:  BMJ Open       Date:  2021-02-05       Impact factor: 2.692

8.  Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event.

Authors:  Michael M Givertz; Mei Yang; Gregory P Hess; Bin Zhao; Ashwin Rai; Javed Butler
Journal:  ESC Heart Fail       Date:  2021-03-10

Review 9.  A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020).

Authors:  Michael Urbich; Gary Globe; Krystallia Pantiri; Marieke Heisen; Craig Bennison; Heidi S Wirtz; Gian Luca Di Tanna
Journal:  Pharmacoeconomics       Date:  2020-11       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.